MedTrace Logo

Efficacy of Subgingival Erythritol Air Polishing in Treatment of Periodontal Pockets

NCT05798871 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2023-04-05

No results posted yet for this study

Summary

Periodontitis is an inflammation associated with destruction of the periodontium that ultimately, if not treated, leads to tooth loss. Clinically, it is characterized by clinical attachment loss (CAL) and bleeding on probing (BOP) accompanied by increased probing pocket depth (PPD) and/or gingival recession. The standard periodontitis treatment aims to restore the homeostasis of the immune system by mechanically reducing the microbial load to levels that are compatible with stability and health. This is achieved by professional mechanical biofilm control and motivation of the patient for oral hygiene measures in order to control the biofilm and avoid disease recurrence. Conventional scaling and root planing (SRP), and air polishing therapy are tools used for professional biofilm control. More recently, air-polishing devices have become a promising alternative to conventional SRP in reducing the clinical time and causing less discomfort and pain for the patients. The objective of this study is to evaluate the efficacy of subgingival erythritol air polishing for initial periodontal pocket healing.

Conditions

  • Periodontal Diseases

Interventions

PROCEDURE

Subgingival erythritol air polishing

The intervention will start with supragingival debridement followed by subgingival erythritol air polishing by perioflow. subgingival debridement

PROCEDURE

Conventional root planing

The intervention will start with supragingival debridement followed by root planing by curette.

Sponsors & Collaborators

  • University of Baghdad

    lead OTHER

Principal Investigators

  • Mohsen K Abbass · University of Baghdad

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-05
Primary Completion
2024-03-31
Completion
2024-09-30

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05798871 on ClinicalTrials.gov